STOCK TITAN

Pediatrix Medical Group (MD) Stock News, Oct 20, 2020

MD NYSE

Pediatrix Medical Group, Inc. provides physician services for women, babies and children across hospital settings and office-based practices. Its recurring updates center on obstetrics, maternal-fetal medicine, neonatology, neonatal intensive care unit activity and other pediatric subspecialties, with revenue concentrated in neonatology and pediatric subspecialty care.

Company news also covers quarterly operating results, same-unit revenue trends, reimbursement and payor-mix factors, patient acuity, hospital contract administrative fees, practice acquisitions and dispositions, service expansions, clinical quality initiatives and neonatology education through NEO: The Conference for Neonatology.

Rhea-AI Summary

MEDNAX, Inc. (NYSE: MD) will host an investor conference call on November 6, 2020, at 9:00 a.m. ET to discuss operational results for Q3 and the first nine months of 2020. A detailed press release will precede the call, focusing on key financial metrics and operational updates. MEDNAX, a leading provider of physician services in the U.S., aims to enhance patient outcomes through quality initiatives and telemedicine. The company has over 3,000 physicians across all 50 states and Puerto Rico.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
conferences

FAQ

What is the current stock price of Pediatrix Medical Group (MD)?

The current stock price of Pediatrix Medical Group (MD) is $25.97 as of October 3, 2026.

What is the market cap of Pediatrix Medical Group (MD)?

The market cap of Pediatrix Medical Group (MD) is approximately 2.1B.